Insurance

For patients who reached the Medicare Part D coverage gap, discontinuation was more likely for patients taking osteoporosis medication.

A formulary restriction policy in a Medicare population was associated with lower celecoxib utilization; however, higher gastrointestinal- and arthritis-related medical costs were observed.

This review article explores the Medicare data available for researchers and approaches that could be used to enhance the data%u2019s value for comparative effectiveness research.

Health plan accounting data are used to test how well the CMSHCC risk adjustment system tracks relative costs of treating various diagnoses: not very well.

An integrated, clinician-focused telehealth monitoring system significantly reduced hospitalizations in Medicare home healthcare patients.

Dr. Jeffrey Dunn shares his opinion on how healthcare reform issues, such as Comparative Effectiveness Research, will impact formulary management.

Although the fundamental structure of Medicare Part D remained the same in 2010, the beneficiary provisions continued to improve.

Greater Medicare managed care benefit levels reduce both the likelihood and magnitude of Veterans Health Administration pharmacy use by Medicare dually enrolled veterans.